FDA quality inspections likely to be lengthy:
This article was originally published in Clinica
Executive Summary
Inspection times under the US FDA's Quality System Inspection Technique (QSIT) that goes into effect in January will take longer than the agency has predicted, according to the Health Industry Manufacturers Association (HIMA). FDA studies suggest that the average QSIT inspection should take 4.7 days. But the Draft Compliance Program Guidance Manual developed in preparation for the QSIT programme asks investigators not only to perform inspections under the quality system regulation but also to conduct inspections of adverse event reports, corrections and removals, tracking, electronic signatures and registration and listing. This is likely to substantially increase the length of time taken by the inspection, HIMA argues. The trade group also questions whether the criteria the FDA will use when it decides to recommend administrative or legal action is overly broad and could therefore result in warning letters after every inspection.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.